Terazosin
- Generic Name
- Terazosin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H25N5O4
- CAS Number
- 63590-64-7
- Unique Ingredient Identifier
- 8L5014XET7
- Background
Terazosin is a quinazoline derivative alpha-1-selective adrenergic blocking agent indicated for benign prostatic hyperplasia and hypertension. Terazosin blocks adrenaline's action on alpha-1 adrenergic receptors, causing relaxation of smooth muscle in blood vessels and the prostate.
- Indication
Terazosin is indicated for use in treating symptomatic benign prostatic hyperplasia and hypertension.
- Associated Conditions
- Benign Prostatic Hyperplasia (BPH), Hypertension, Ureteral Calculus
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath